SHOCKWAVE C2 CORONARY INTRAVASCULAR LITHOTRIPSY (IVL) CATHETER
Report
- Report Number
- 3015053858-2024-00117
- Event Type
- Injury
- Date Received
- October 9, 2024
- Report Date
- October 9, 2024
- Manufacturer
- SHOCKWAVE MEDICAL, INC.
- Product Code
- QMG
- PMA / PMN Number
- P200039
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NL
- Reporter Occupation
- OTHER
Narratives
THE DEVICE REFERENCED IN THE JOURNAL PUBLICATION WAS NOT AVAILABLE FOR RETURN TO SHOCKWAVE MEDICAL INC. THE DEVICE LOT NUMBER OR SIZE WAS NOT REPORTED, THEREFORE, ADDITIONAL INFORMATION COULD NOT BE OBTAINED. THE CAUSE OF THE REPORTED PERFORATION COULD NOT BE DETERMINED BASED ON THE INFORMATION AVAILABLE IN THE JOURNAL. THERE WAS NO REPORT OF ANY IVL DEVICE MALFUNCTION. A REVIEW OF THE DEVICE MANUFACTURING AND TEST DOCUMENTATION COULD NOT BE COMPLETED WITH THE LIMITED INFORMATION AVAILABLE. HOWEVER, SHOCKWAVE MEDICAL, INC. HAS CONTROLS IN PLACE TO ENSURE DEVICES ARE BUILT TO APPROVED PROCEDURES AND MEET LOT RELEASE ACCEPTANCE CRITERIA PRIOR TO DISTRIBUTION.
AN ARTICLE RELATED TO INTRAVASCULAR LITHOTRIPSY (IVL) IN CHRONIC TOTAL OCCLUSIONS (CTO) PERCUTANEOUS CORONARY INTERVENTIONS REPORTING PERFORATIONS AND LIFE-THREATENING ARRHYTHMIAS ENTITLED "INTRAVASCULAR LITHOTRIPSY IN HEAVILY CALCIFIED CHRONIC TOTAL OCCLUSION: PROCEDURAL AND ONE-YEAR CLINICAL OUTCOMES" WAS PUBLISHED IN THE CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS JOURNAL BY WILEY PERIODICALS LLC (DOI: 10.1002/CCD.31207). THERE IS NO AVAILABLE INFORMATION ON PRODUCT TYPE, PATIENTS' HEALTH HISTORY, PROCEDURE/EVENT DATE, OR CAUSAL DEVICE RELATIONSHIP. THIS IS REPORT 1 OF 3 ASSOCIATED TO THIS PUBLICATION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2260197 | SHOCKWAVE C2 CORONARY INTRAVASCULAR LITHOTRIPSY (IVL) CATHETER | SHOCKWAVE C2 CORONARY INTRAVASCULAR LITHOTRIPSY (IVL) CATHETER | QMG | SHOCKWAVE MEDICAL, INC. | C2IVLXXXXX | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | Other |